MUTATION AATAAA->AATAAG of the alpha2 gene (poly A signal)
 
AMINO ACID REPLACEMENT None
TYPE OF ALPHA-THAL alpha-Thal-2 [alpha(T)alpha/alphaalpha]
MECHANISM This mutation in the poly A signal results in an extended transcript with a new signal 1048 bp 3' to the terminating codon; nonfunctional mRNA
IDENTIFICATION Cloning or amplification of the alpha2-globin gene; DNA se-quencing; dot-blot analysis with allele specific probes; ASO
HEMATOLOGY IN HETEROZYGOTE(S) For hematological and Hb composition data see table from Ref. 4 (below)
Sex-Age Hb
g/dl
PCV
l/l
RBC
1012/l
MCV
fl
MCH
pg
MCHC
g/dl
A2
%
% H +
Bart's

Homozygotes (n = 7)
F-10
M-14
F-42
F-21
M-16
Adult
M-13
7.0
7.0
9.7
9.0
9.9
7.7
8.6
0.289
0.295
0.424
0.393
0.421
0.290
0.306
3.94
3.90
5.25
4.72
5.14
4.05
4.37
73.4
75.6
80.5
83.5
82.0
71.6
70.0
17.8
17.9
18.4
19.1
19.3
19.0
19.5
24.2
23.7
22.9
23.5
26.6
28.0
28.1
0.7
1.4
0.6
0.7
0.7
0.8
1.4
14.0
6.5
7.0
20.0
25.0
n.d.
17.0
Average 8.40.3454.4877.018.824.30.915.0

Heterozygotes (n = 10)
F-adult
M-adult
F-adult
M-adult
M-adult
M-adult
M-adult
M-adult
F-adult
F-adult
12.6
12.6
10.9
13.3
10.8
16.4
15.2
13.5
14.6
11.9
0.459
0.460
0.377
0.465
0.381
0.560
0.476
0.418
0.451
0.352
5.12
5.15
4.37
5.22
4.64
6.60
5.80
5.10
5.50
4.60
89.6
89.3
86.3
89.1
82.1
84.3
82.1
82.0
82.0
77.0
24.6
24.5
24.9
25.5
23.3
24.7
26.2
26.5
26.5
25.8
27.5
27.4
28.9
28.6
28.3
29.3
31.9
32.3
32.1
33.8
2.2
2.5
2.4
2.5
2.4
2.2
2.1
2.4
2.7
2.8
0
0
0
0
0
0
0
0
0
0
Average 13.20.4405.2184.525.330.02.40

HEMATOLOGY IN HOMOZYGOTE(S) Homozygosity expresses as Hb H disease probably because the presence of an extended transcript reduces the expression of the 3' alpha1-globin gene
OCCURRENCE In Arabian populations
HAPLOTYPE Not determined
FOUND IN COMBINATION WITH ABNORMAL HB(S) Not reported
FOUND IN COMBINATION With different alpha-thal alleles (deletional and nondeletional mutations)
OTHER INFORMATION None
       
REFERENCES
1. Higgs, D.R., Goodbourn, S.E.Y., Lamb, J., Clegg, J.B., Weatherall, D.J., and Proudfoot, N.J.: Nature, 306:398, 1983.
2. Thein, S.L., Wallace, R.B., Pressley, L., Clegg, J.B., Weatherall, D.J., and Higgs, D.R.: Blood, 71:313, 1988.
3. Whitelaw, E. and Proudfoot, N.: EMBO J., 5:2915, 1986.
4. Fei, Y-J., Oner, R., Bozkurt, G., Gu, L-H., Altay, Ç., Gurgey, A., Fattoum, S., Baysal, E., and Huisman, T.H.J.: Acta Haematol., 88:82, 1992.
5. Adekile, A.D., Gu, L-H., Baysal, E., Haider, M.Z., Al-Fuzae, L., Aboobacker, K.C., Al-Rashied, A., and Huisman, T.H.J.: Acta Haematol., 92:176, 1994.


This material is from the book A Syllabus of Thalassemia Mutations (1997) by Titus H.J. Huisman, Marianne F.H. Carver, and Erol Baysal, published by The Sickle Cell Anemia Foundation in Augusta, GA, USA. Copyright © 1997 by Titus H.J. Huisman. All rights reserved. Neither this work nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, microfilming and recording, or by any information storage and retrieval systems, without permission in writing from the Author.